Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668.
PMID:15481055
Blinatumomab, a Bispecific T-cell Engager (BiTE()) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications.
Zhu M, Wu B, Brandl C, Johnson J, Wolf A, Chow A, Doshi S.
Acute Lymphoblastic Leukemia Detection and Classification of Its Subtypes Using Pretrained Deep Convolutional Neural Networks.
Shafique S, Tehsin S.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818802789. doi: 10.1177/1533033818802789.
PMID:30261827
Acute Lymphoblastic Leukemia in Combined Methylmalonic Acidemia and Homocysteinemia (cblC Type): A Case Report and Literature Review.
Zhu J, Wan S, Zhao X, Zhu B, Lv Y, Jiang H.
Front Genet. 2022 Apr 14;13:856552. doi: 10.3389/fgene.2022.856552. eCollection 2022.
PMID:35495149
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
Ahmed IO, Ochogwu LO, Owojuyigbe TO, Akinola NO, Durosinmi MA.
J Med Case Rep. 2021 Oct 8;15(1):504. doi: 10.1186/s13256-021-03060-5.
PMID:34625105
RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.
Yamamoto K, Kitao A, Watanabe M, Kanehira H, Joyce M, Hirakawa Y, Matsumoto S, Yakushijin K, Minami H.
J Clin Exp Hematop. 2023 Dec 26;63(4):240-245. doi: 10.3960/jslrt.23028. Epub 2023 Oct 28.
PMID:37899239
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller P, Baran N, Harutyunyan K, Cavazos A, Mallampati S, Chin RL, Jiang Z, Sun X, Lee HH, Hsu JL, Williams P, Huang X, Curran MA, Hung MC, Konopleva M.